Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0760
E

Administration of Contraindicated Medications Despite Documented Allergies

Tamaqua, Pennsylvania Survey Completed on 11-25-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident's medication regimen was free from significant medication errors. A review of clinical records, facility policy, pharmacy records, and interviews revealed that a resident with documented allergies and intolerances to several medications, including Ondansetron and Gabapentin, was administered these medications despite their allergy status. The resident's medical history included Type 2 Diabetes, congestive heart failure, and nausea and vomiting. The facility's policy required staff to verify medication allergies and obtain vital signs as applicable before administering medications. However, the resident received Ondansetron on ten occasions and Gabapentin daily for over two weeks, even though both were listed as allergies or intolerances in the resident's records. The resident reported being aware of her allergy to Ondansetron and stated that it caused her to vomit, which she had previously communicated to her physician. There was no documentation provided by the facility to show that the physician justified the use of these medications despite the allergy listings. Additionally, the consultant pharmacist's monthly reviews did not identify or recommend discontinuation of the contraindicated medications. The Nursing Home Administrator acknowledged that the medications were administered despite the documented allergies and that no physician justification could be provided.

An unhandled error has occurred. Reload 🗙